
CCX-354
CAS No. 1010073-75-2
CCX-354( GSK-2941266 | CCX354 | CCX354-C )
Catalog No. M10066 CAS No. 1010073-75-2
CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 626 | Get Quote |
![]() ![]() |
10MG | 888 | Get Quote |
![]() ![]() |
25MG | 1332 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
500MG | 4410 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCCX-354
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases.
-
DescriptionCCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases such as rheumatoid arthritis (RA).Rheumatoid Arthritis Phase 2 Clinical.
-
In VitroCCX354 shows potent activities in the chemotaxis assay, with IC50 < 100 nM.
-
In VivoIn vivo, CCX354 has in vivo anti-inflammatory activity and has superior pharmacokinetic properties.
-
SynonymsGSK-2941266 | CCX354 | CCX354-C
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research AreaInflammation/Immunology
-
IndicationRheumatoid Arthritis
Chemical Information
-
CAS Number1010073-75-2
-
Formula Weight451.915
-
Molecular FormulaC22H22ClN7O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (221.28 mM)
-
SMILESCOC1=C(C=CC(=C1)N2CCN(CC2)C(=O)CN3C4=C(C=CC=N4)C(=N3)C5=NC=CN5)Cl
-
Chemical Name2-(3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)-1-(4-(4-chloro-3-methoxyphenyl)piperazin-1-yl)ethan-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tak PP, et al. Ann Rheum Dis. 2013 Mar;72(3):337-44.
2. Harcken C, et al. Bioorg Med Chem Lett. 2018 Nov 9. pii: S0960-894X(18)30880-1.
molnova catalog



related products
-
RS-102895 hydrochlor...
A potent and specific CCR2 antagonist with binding IC50 of 360 nM; shows no significant affinity on CXCR1, CCR1, or CCR3.
-
E 6130
A potent, selective, orally available CX3C chemokine receptor 1 (CX3CR1) modulator that inhibits the fractalkine-induced chemotaxis of human peripheral blood NK cells with IC50 of 4.9 nM.
-
Ladarixin sodium
A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM.